文献速递神经MR

基于影像的深度学习识别胶质母细胞瘤风险组及其基因组与转录组异质性:多中心研究

Image-based deep learning identifies glioblastoma risk groups with genomic and transcriptomic heterogeneity: a multi-center study.
PubMed 文献 · Eur Radiol · 2022-08-24

该多中心研究基于多参数MRI开发并验证了深度学习影像签名(DLIS),用于胶质母细胞瘤(GBM)的风险分层。DLIS与生存显著相关(log-rank p < 0.001)且为独立预测因子(p < 0.001),整合DLIS的列线图C指数优于临床分子列线图(NRI 0.39,p < 0.001)。DLIS与GBM核心通路(凋亡、细胞周期相关P53和RB通路、细胞增殖相关RTK通路)及关键遗传 alteration(del_CDKN2A)显著相关。

要点

  • DLIS基于多参数MRI可对GBM进行风险分层,与生存显著相关且为独立预测因子。
  • DLIS与P53、RB、RTK通路及del_CDKN2A突变相关,具有生物学可解释性。
  • 整合DLIS的列线图较临床分子列线图改善预测性能(NRI 0.39)。

核心结论

  • DLIS是一个具有生物学可解释性的深度学习生存预测因子,有助于理解GBM预后并指导个体化治疗。

研究设计与样本

  • DLIS基于多参数MRI开发,训练集n=600,内部验证集n=164,外部测试集1 n=100,外部测试集2 n=161,公共TCIA集n=88。
  • radiogenomics分析数据集n=127,整合影像、转录组和基因组多尺度高维数据以揭示DLIS的生物学基础。

诊断标准与关键数值

  • DLIS与生存相关(log-rank p < 0.001),且为独立预测因子(p < 0.001)。
  • 整合DLIS的列线图C指数优于临床分子列线图(NRI 0.39,p < 0.001)。
  • DLIS与凋亡、细胞周期相关P53和RB通路、细胞增殖相关RTK通路显著相关,并与del_CDKN2A相关。
  • DLIS相关基因的预后价值在TCGA/CGGA集中外部验证(p < 0.01)。

临床应用与阅片要点

  • DLIS可作为GBM风险分层的影像学工具,辅助预后评估和个体化治疗决策。
  • DLIS与特定分子通路和遗传 alteration的关联提示其可用于无创推断GBM分子特征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To develop and validate a deep learning imaging signature (DLIS) for risk stratification in patients with multiforme (GBM), and to investigate the biological pathways and genetic alterations underlying the DLIS.

METHODS: The DLIS was developed from multi-parametric MRI based on a training set (n = 600) and validated on an internal validation set (n = 164), an external test set 1 (n = 100), an external test set 2 (n = 161), and a public TCIA set (n = 88). A co-profiling framework based on a radiogenomics analysis dataset (n = 127) using multiscale high-dimensional data, including imaging, transcriptome, and genome, was established to uncover the biological pathways and genetic alterations underpinning the DLIS.

RESULTS: The DLIS was associated with survival (log-rank p < 0.001) and was an independent predictor (p < 0.001). The integrated nomogram incorporating the DLIS achieved improved C indices than the clinicomolecular nomogram (net reclassification improvement 0.39, p < 0.001). DLIS significantly correlated with core pathways of GBM (apoptosis and cell cycle-related P53 and RB pathways, and cell proliferation-related RTK pathway), as well as key genetic alterations (del_CDNK2A). The prognostic value of DLIS-correlated genes was externally confirmed on TCGA/CGGA sets (p < 0.01).

CONCLUSIONS: Our study offers a biologically interpretable deep learning predictor of survival outcomes in patients with GBM, which is crucial for better understanding GBM patient's prognosis and guiding individualized treatment.

KEY POINTS: • MRI-based deep learning imaging signature (DLIS) stratifies GBM into risk groups with distinct molecular characteristics. • DLIS is associated with P53, RB, and RTK pathways and del_CDNK2A mutation. • The prognostic value of DLIS-correlated pathway genes is externally demonstrated.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Yan, Sun, Tan, et al. Image-based deep learning identifies glioblastoma risk groups with genomic and transcriptomic heterogeneity: a multi-center study. Eur Radiol. 2022. PMID: 36001125. doi:10.1007/s00330-022-09066-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。